At Sanger Avenue Medical Aesthetics, we're proud to offer DAXXIFY®, the first true innovation in frown line treatment formulation in more than 20 years, and the only neuromodulator powered by a proprietary peptide rather than human or animal byproducts.
DAXXIFY® does everything you'd expect from a premium neuromodulator (it smooths moderate to severe frown lines, relaxes overactive facial muscles, and produces a natural and refreshed appearance). But it does something the others can't: it works faster, lasts significantly longer, and improves the overall appearance of skin quality in the treated area.
94% of patients preferred DAXXIFY® over their previous frown line treatment as soon as week 2.
As with all injectable treatments at Sanger Avenue Medical Aesthetics, DAXXIFY® is performed exclusively by Dr. Patricia Wilcox, M.D.
Fast
Results as early as the next day - and typically within 2 days. Most patients notice improvement before they've even left the first week behind.
Lasting
While conventional neuromodulators last a median of 3-4 months, at least 50% of DAXXIFY® patients in clinical studies had no or mild frown lines at 6 months. Results soften gradually over an extended period (meaning no sudden drop-off).
Better Look
64% of patients achieved an improvement in the appearance of skin texture at week 2.
98% achieved none or mild wrinkle severity at week 4.
It doesn't just treat the lines, it improves the overall quality of skin in the treated area.
DAXXIFY® treatment follows the same general phases as other neuromodulators, but with a meaningfully extended timeline:
DAXXIFY® is a neuromodulator - like Botox and Dysport, it temporarily relaxes the muscles that cause frown lines between the eyebrows. What sets it apart is the formulation. DAXXIFY® is powered by Peptide Exchange Technology™, a proprietary peptide that replaces the human serum albumin stabilizer used in other neuromodulators. This unique formulation helps the toxin work faster and last significantly longer than convention options. While Botox and Dysport typically last a median of 3 to 4 months, at least 50% of DAXXIFY® patients in clinical studies had no or mild frown lines at 6 months after treatment.
DAXXIFY® works faster than most neuromodulators. Results are typically visible within 2 days - and some patients notice improvement as early as the next day. Peak effectiveness is reached at around 4 weeks, when nearly all patients achieve none or mild frown lines.
Results vary by individual, but clinical data shows that at least 50% of patients had no or mild frown lines 6 months after treatment. Some patients maintain results beyond that. The softening is gradual and results don't drop off suddenly, but ease back to baseline over an extended period. This means you get more total time looking your best between appointments, and many patients find they only need two treatments per year rather than three or four.
Yes, this is one of DAXXIFY®'s most notable qualities. In clinical studies 64% of patients achieved an improvement in the appearance of skin texture at week 2, and skin quality improvement was observed through week 24. This is a benefit that goes beyond what most neuromodulators deliver.
Yes! Units are not interchangeable between different neuromodulators. They are a proprietary measurement of each product's unique potency, and you cannot directly compare or convert units between DAXXIFY® and Botox, Dysport or any other neuromodulator. Dr. Wilcox will determine the appropriate dosage of DAXXIFY® for your treatment at your appointment.
DAXXIFY®'s safety profile has been established across the largest clinical trial program ever conducted for a frown line treatment. There were no serious treatment-related adverse events in the three DAXXIFY® clinical trials. The most commonly observed side effects were headache (6%), eyelid drooping (2%), and facial peresis (1%). As with all botulinum toxin products, there is a boxed warning regarding the potential spread of toxin effects - that information can be found below but is also available upon request at our office.
Safety information
DAXXIFY® is not recommended for patients who are pregnant or breastfeeding, patients with hypersensitivity to any botulinum toxin prearation, or patients with an active skin infection at the planned injection site. Patients with pre-existing cardiovascular disease, neuromuscular disorders, or swallowing or breathing difficulties require special consideration. Tell Dr. Wilcox about all medications you're currently taking, includng any other botulinum toxin products received in the last 4 months. Dr. Wilcox will review your full medical history at your consultation.
DAXXIFY® is a neuromodulator and pairs most naturally with dermal fillers for comprehensive facial rejuvenation. DAXXIFY® handles dynamic expression lines while fillers restore volume and address static wrinkles. Because DAXXIFY® lasts significantly longer than conventional neuromodulators, many patients find they can time their filler appointments to align with their DAXXIFY® schedule, reducing the overall frequency of visits.
For patients wanting a more complete approach, DAXXIFY® combines well with Morpheus8 or SkinPen for skin tightening and texture, NouvaDERM for overall tone and radiance, and exosome therapy for skin quality enhancement.
Medical-grade skincare from our SkinCeuticals or Hydrinity lines supports and extends your injectable results between appointments.
Ready to experience faster results that last longer? Book your consultation at Sanger Avenue Medical Aesthetics in Waco with Dr. Patricia Wilcox, M.D.
View All Services